Safety and efficacy of the HVTN 503/Phambili study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study (Q36158727)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety and efficacy of the HVTN 503/Phambili study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study |
scientific article |
Statements
1 reference
Safety and efficacy of the HVTN 503/Phambili study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study (English)
1 reference
Linda-Gail Bekker
1 reference
Lawrence Corey
1 reference
Glenda E Gray
1 reference
M Julie McElrath
1 reference
Zoe Moodie
1 reference
Gavin Churchyard
1 reference
Barbara Metch
1 reference
Guy de Bruyn
1 reference
Maphoshane Nchabeleng
1 reference
Surita Roux
1 reference
Matsontso Mathebula
1 reference
HVTN 503/Phambili study team
1 reference
James G Kublin
1 reference
Mary H Latka
1 reference
Nivashnee Naicker
1 reference
Constance Ducar
1 reference
Donald K Carter
1 reference
Adrien Puren
1 reference
Niles Eaton
1 reference
Michael Robertson
1 reference
11 May 2011
1 reference
1 reference
507-515
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference